Yahong Wu

2.0k total citations · 1 hit paper
58 papers, 1.6k citations indexed

About

Yahong Wu is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Yahong Wu has authored 58 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Immunology, 26 papers in Molecular Biology and 16 papers in Oncology. Recurrent topics in Yahong Wu's work include Immunotherapy and Immune Responses (21 papers), Immune Cell Function and Interaction (12 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Yahong Wu is often cited by papers focused on Immunotherapy and Immune Responses (21 papers), Immune Cell Function and Interaction (12 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Yahong Wu collaborates with scholars based in China and New Zealand. Yahong Wu's co-authors include Yanfeng Gao, Wenjie Zhai, Yuanming Qi, Bin Yu, Yihui Song, Kai Tang, Xiuman Zhou, Zhenzhen Chen, Guanyu Chen and Xianqing Wu and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and Nano Letters.

In The Last Decade

Yahong Wu

57 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy

2021 246 citations Kai Tang, Yahong Wu et al. Journal of Hematology & Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yahong Wu China	22	807	723	468	217	178	58	1.6k
Zaheed Husain United States	18	753 0.9×	612 0.8×	361 0.8×	465 2.1×	35 0.2×	27	1.7k
Alain Piché Canada	27	556 0.7×	994 1.4×	680 1.5×	294 1.4×	49 0.3×	57	1.9k
Xiangliang Yuan China	22	1.1k 1.3×	1.6k 2.3×	786 1.7×	860 4.0×	259 1.5×	38	2.8k
Hongmin Chen United States	19	398 0.5×	786 1.1×	282 0.6×	160 0.7×	105 0.6×	33	1.6k
Nadia Guerra United Kingdom	22	1.7k 2.1×	327 0.5×	868 1.9×	151 0.7×	58 0.3×	32	2.2k
Kris F. Sachsenmeier United States	18	565 0.7×	664 0.9×	740 1.6×	110 0.5×	154 0.9×	46	1.7k
Mattias Carlsten Sweden	28	2.4k 3.0×	621 0.9×	1.5k 3.3×	95 0.4×	93 0.5×	63	3.1k
Yingying Shen China	23	408 0.5×	920 1.3×	254 0.5×	366 1.7×	202 1.1×	51	1.5k
Joaquín Manzo-Merino Mexico	15	254 0.3×	714 1.0×	288 0.6×	503 2.3×	98 0.6×	40	1.3k
Kamir J. Hiam-Galvez United States	8	838 1.0×	494 0.7×	726 1.6×	153 0.7×	197 1.1×	13	1.7k

Countries citing papers authored by Yahong Wu

Since Specialization

Citations

This map shows the geographic impact of Yahong Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yahong Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yahong Wu more than expected).

Fields of papers citing papers by Yahong Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yahong Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yahong Wu. The network helps show where Yahong Wu may publish in the future.

Co-authorship network of co-authors of Yahong Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yahong Wu. A scholar is included among the top collaborators of Yahong Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yahong Wu. Yahong Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Chen, Wentao, Yahong Wu, Zhen Guo, et al.. (2025). CNS Mitochondria‐Derived Vesicle in Blood: Potential Biomarkers for Brain Mitochondria Dysfunction. Annals of Clinical and Translational Neurology. 12(7). 1312–1323. 1 indexed citations

2.

Zhu, Xueqin, Xiaoxi Wang, Bing Jiang, et al.. (2024). Peroxidase‐Like Nanozyme Activates the cGAS‐STING Pathway via ROS‐Induced mtDNA Release for Cancer Immunotherapy. Advanced Functional Materials. 34(39). 21 indexed citations

3.

Tang, Kai, Min Zhao, Yahong Wu, et al.. (2022). Structure-based design, synthesis and biological evaluation of aminopyrazines as highly potent, selective, and cellularly active allosteric SHP2 inhibitors. European Journal of Medicinal Chemistry. 230. 114106–114106. 10 indexed citations

4.

Wang, Zhiwei, Ling Ran, Chunxia Chen, et al.. (2021). Identification of HLA-A2-Restricted Mutant Epitopes from Neoantigens of Esophageal Squamous Cell Carcinoma. Vaccines. 9(10). 1118–1118. 2 indexed citations

5.

Dong, Yu, Yanfeng Gao, Yubing Li, et al.. (2021). Identification of CTL Epitopes on Efflux Pumps of the ATP-Binding Cassette and the Major Facilitator Superfamily of Mycobacterium tuberculosis. Journal of Immunology Research. 2021. 1–13. 4 indexed citations

6.

Zhou, Xiuman, Yixuan Sun, Wei Zheng, et al.. (2021). Repositioning Azelnidipine as a Dual Inhibitor Targeting CD47/SIRPα and TIGIT/PVR Pathways for Cancer Immuno-Therapy. Biomolecules. 11(5). 706–706. 30 indexed citations

7.

Tang, Kai, Yahong Wu, Yihui Song, & Bin Yu. (2021). Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy. Journal of Hematology & Oncology. 14(1). 68–68. 246 indexed citations breakdown →

8.

Yao, Yongjie, Xiaoxi Wang, Jiaxin Sun, et al.. (2021). Interleukin-36α inhibits colorectal cancer metastasis by enhancing the infiltration and activity of CD8+ T lymphocytes. International Immunopharmacology. 100. 108152–108152. 4 indexed citations

9.

Yang, Jiali, Shuyi Song, Yahong Wu, et al.. (2021). 4-Hydroxyisoleucine Alleviates Macrophage-Related Chronic Inflammation and Metabolic Syndrome in Mice Fed a High-Fat Diet. Frontiers in Pharmacology. 11. 606514–606514. 16 indexed citations

10.

Li, Wanqiong, Xueqin Zhu, Xiuman Zhou, et al.. (2021). An orally available PD-1/PD-L1 blocking peptide OPBP-1-loaded trimethyl chitosan hydrogel for cancer immunotherapy. Journal of Controlled Release. 334. 376–388. 73 indexed citations

11.

Song, Yihui, Min Zhao, Yahong Wu, Bin Yu, & Hong‐Min Liu. (2020). A multifunctional cross-validation high-throughput screening protocol enabling the discovery of new SHP2 inhibitors. Acta Pharmaceutica Sinica B. 11(3). 750–762. 24 indexed citations

12.

Li, Dezhi, et al.. (2020). Identification of Novel Cytotoxic T Lymphocyte Epitopes of Drug- Resistance Related Protein InhA from Mycobacterium tuberculosis. Protein and Peptide Letters. 27(11). 1141–1150. 3 indexed citations

13.

Zhou, Xiuman, Chao Zuo, Wanqiong Li, et al.. (2020). A Novel d‐Peptide Identified by Mirror‐Image Phage Display Blocks TIGIT/PVR for Cancer Immunotherapy. Angewandte Chemie International Edition. 59(35). 15114–15118. 121 indexed citations

14.

Zhou, Xiuman, Chao Zuo, Wanqiong Li, et al.. (2020). A Novel d‐Peptide Identified by Mirror‐Image Phage Display Blocks TIGIT/PVR for Cancer Immunotherapy. Angewandte Chemie. 132(35). 15226–15230. 2 indexed citations

15.

Wang, Hongfei, Yixuan Sun, Xiuman Zhou, et al.. (2020). CD47/SIRPα blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy. Journal for ImmunoTherapy of Cancer. 8(2). e000905–e000905. 101 indexed citations

16.

Wu, Yahong & Xianqing Wu. (2019). [Expression of PROK 1 and its receptor PROKR 1 in endometriosis and its clinical significance].. PubMed. 44(6). 621–627. 3 indexed citations

17.

Wu, Yahong, Wenyu Chen, Zhifen Pan, et al.. (2016). Effect of psychological nursing on anxiety and depression and quality of life of patients with multi-drug resistant pulmonary tuberculosis. Zhongguo jiceng yiyao. 23(19). 2923–2927. 1 indexed citations

18.

Chen, Fei, Yuanyuan Zhao, Yahong Wu, et al.. (2015). Novel epitopes identified from efflux pumps of Mycobacterium tuberculosis could induce cytotoxic T lymphocyte response. PeerJ. 3. e1229–e1229. 6 indexed citations

19.

Wang, Ting, Xilong Liu, Zhenyu Ji, et al.. (2015). Antitumor and immunomodulatory effects of recombinant fusion protein rMBP-NAP through TLR-2 dependent mechanism in tumor bearing mice. International Immunopharmacology. 29(2). 876–883. 15 indexed citations

20.

Yang, Yan, Yuan Jiang, Yahong Wu, et al.. (2006). [Evaluation on quitting intervention in health professionals of six cities].. PubMed. 35(1). 89–91. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact